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Abstract
Mozambique introduced the monovalent rotavirus vaccine (Rotarix®, GSK Biologicals, Rix-
ensart, Belgium) in September 2015. Previous analysis, showed that Nampula province
continues reporting a high frequency of Rotavirus A (RVA) infection and the emergence of
G9P[6], G9P[4] and G3P[4] genotypes. This analysis aimed to determine the RVA fre-
quency; risk factors; genotype distribution by vaccination status and age between pre- and
post-vaccine periods in children under-five years old with diarrhea in Nampula. A cross-sec-
tional, hospital-based surveillance study was conducted in the Hospital Central de Nampula
in Mozambique. Socio-demographic and clinical data were collected to assess factors
related to RVA infection in both periods. Stool specimens were screened to detect RVA by
ELISA, and positive samples were genotyped. Between 2015 (pre-vaccine period) and
2016–2019 (post-vaccine period), 614 stool specimens were collected and tested for RVA
in which 34.9% (67/192) were positive in pre-vaccine period and 21.8% (92/422) in post-vac-
cine (p = 0.001). In the post-vaccine period, age, year, and contact with different animal spe-
cies (chicken, duck, or multiple animals) were associated with RVA infection. RVA infection
was higher in children partially vaccinated (40.7%, 11/27) followed by the fully vaccinated
(29.3%, 56/191) and the unvaccinated (15.3%, 21/137) (p = 0.002). G1P[8] and G9P[4]
were common in vaccinated children less than 12 months. The present analysis showed
that RVA infection reduced slightly in the post-vaccine period, with a high proportion of
infection and genotype diversity in children, under 12 months of age, vaccinated. Further
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Introduction
Globally, Rotavirus A (RVA) remains the leading cause of severe acute gastroenteritis associ-
ated with high childhood hospitalization and mortality, accounting for an estimated 128,515
deaths among children under five years old in 2016 [1, 2]. In Sub-Saharan Africa, RVA associ-
ated morbidity and mortality is exceptionally high with approximately 104,733 children dying
annually from the disease [3]. In 2009, the World Health Organization (WHO) recommended
the introduction of RVA vaccine in all countries, particularly in those with high child mortality
[4]. In 2021, four attenuated oral rotavirus vaccines are licensed and available globally:
Rotarix1 (GlaxoSmithKline Biologics, Rixensart, Belgium), RotaTeq1 (Merck & Co., USA),
Rotavac1 (Bharat Biotech, India), and Rotasiil1 (Serum Institute of India Pvt. Ltd. India) [5].
A systematic review of the RVA vaccination impact on hospitalizations and deaths from 27
countries, found a 67% reduction in children’s hospitalization and outpatient care and a 60%
decline in childhood mortality due to RVA gastroenteritis in 2016 [6]. Rotavirus morbidity
decreased from 38% to 23% in 82 countries between 2008 and 2016 [7].
Studies of molecular characterization of RVA have shown that globally G1P[8] is the most
common genotype combination, followed by G2P[4], G3P[8], G4P[8], and G9P[8] [8–11].
Following the introduction of the RVA vaccine (Rotarix1 and Rotateq1), new RVA strains
were reported in Southern and Eastern African countries (Angola, Eritrea, Ethiopia, Kenya,
Lesotho, Madagascar, Mauritius, Namibia, Rwanda, Seychelles, Swaziland, Tanzania, Uganda,
Zambia and Zimbabwe) between 2010 and 2015; these included: G1P[4], G2P[8], G9P[4], and
G12P[4] [11]. Before the RVA vaccine introduction in Mozambique, RVA was identified as
the principal etiologic agent of moderate-severe-diarrhea with an attributable fraction of
34.8% in children under one year in the southern region of Mozambique [12]. Other studies in
children with diarrhea conducted in the southern region (Chókwè, Maputo city, and Manhiça)
showed RVA frequencies ranging from 24% to 42.4% [13, 14]. Those studies reported mostly
the following circulating genotypes: G12P[8] (57%) and G1P[8] (9%) in Chòkwé, G2P[4]
(39.4%) in Manhiça and G12P[6] (28.6%) in Maputo city [14, 15]. Mozambique introduced
the G1P[8] rotavirus vaccine (Rotarix1) into the expanded program of immunization in Sep-
tember 2015. Before Rotarix1 introduction, the Instituto Nacional de Saúde (INS) imple-
mented the National Surveillance of Diarrhea (ViNaDia) in four provinces of the country as a
platform to monitor diarrhea cases, the main etiologies, and risk factors associated with RVA
infection before and after Rotarix1 introduction in the country. ViNaDia data indicated a
high diversity of RVA genotypes across the country, were uncommon combinations such as
G3P[4], G9P[4], G9P[6], G2P[6], and non-typeable genotypes in Nampula province were seen
[16]. ViNaDia also reported a high proportion of undernourished children with the double
burden of RVA and HIV [17]. An independent analysis of RVA in Nampula is relevant
because recurrent reports of poorer health indicators in children are described, including a
high burden of conditions such as undernourishment, malaria, diarrhea and successive cholera
outbreaks [18, 19]. Thus, the present analysis aims to determine RVA frequency, potential risk
factors and the distribution of RVA genotypes by vaccination status and age among children
with diarrhea attending Hospital Central de Nampula, in the pre- and post-vaccine periods.
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Materials and methods
Study design, site, population
A cross-sectional, hospital-based surveillance was conducted between the pre-vaccine (March
—December 2015) and post-vaccine (January 2016 –December 2019) periods. The surveil-
lance was conducted at the Hospital Central de Nampula (HCN) in Nampula province, located
in the northern region of Mozambique. Nampula province is highly populated, and has enor-
mous challenges related to Water, Sanitation and Hygiene (WASH), high levels of poverty,
and lower vaccination coverage [19, 20]. Children aged up to 59 months who presented to the
HCN pediatric services with diarrhea, defined as the passage of three or more loose or liquid
stools in the last 24 hours before seeking healthcare, were surveyed [21]. Children were not
included in this analysis if the caregivers did not consent to their participation as well as
children diagnosed with nosocomial diarrhea. Moreover, children considered overweight
(+2 < Z-score� +5) or with outlier Z-scores values were excluded from the nutritional status
analysis [22].
Data collection
Data was collected by interviewing the child’s caregiver and by accessing the child’s medical
records. The main variables include age (in months), categorized as 0–11, 12–23, 24–59; sex;
exclusive breastfeeding; the age of weaning in months, categorized by six months; animal con-
tact and type of animal; source of drinking water; HIV status; admission type; number of diar-
rhea episodes in the last 24h; vomit; fever; weight; vaccination status, and nutritional status
that was estimated through the weight-for-age Z-score (WAZ), specific to underweight, using
WHO software Anthro version 3.2.2. Weight was measured by lying down children younger
than two years, and standing for children with two years or older. Children were classified as
well-nourished if the Z-score was between -2� Z-score� +2 and as underweighted if the z-
scores was between -6� Z-score< -2. Vaccination status of the children was confirmed with a
valid vaccination card. Trained healthcare professionals of ViNaDia, completed all informa-
tion on a structured data collection form.
Sample collection
ViNaDia methodology has been previously described elsewhere [16, 17, 23, 24]. Briefly, a sin-
gle stool specimen (10 ml) was collected from each child in a polyester container and stored at
-20˚C until shipment, once a week, to the INS laboratory in Maputo for diagnosis.
Laboratory procedures
Collected samples were tested for RVA using the commercial enzyme-immuno-sorbent assay
(ELISA) kit (Prospect, Oxoid Ltd, United Kingdom) according to the manufacturer’s instruc-
tions. All positive samples were submitted to total RNA extraction using the QIAamp Viral
RNA protocol (QIAGEN, Hilden, Germany) following the manufacturer’s instructions.
Extracted RNA (8μl) was reverse transcribed and amplified using a reverse-transcription
polymerase chain reaction (RT-PCR) with Avian Myeloblastosis Virus (AMV), reverse tran-
scriptase (Ivitrogen, USA), Taq DNA polymerase (Ivitrogen, USA) and the primers sBeg9/
End9 for the VP7 encoding gene (1062pb) and Con2/Con3 for the partial VP4-encoding gene
(VP8�, 876bp) were used [25, 26]. Amplicon products from the first round RT-PCR were
added to a second-round multiplex semi-nested PCR containing RVG9 and specific primers
for G-type (G1-4, G9-10, and G12) identification were used as described elsewhere [16, 25,
27, 28].
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Similarly, Con3 was used in combination with specific primers that identify P-types (P[4],
P[6], P[8], P[9], P[11], and P[14]) as previously described [16, 26, 29]. The cycling conditions
consisted of 1 minute denaturation, followed by 30 cycles of dsRNA denaturation for 1 minute
at 95˚C, annealing for 1 minute at 42˚C, 1 minute at 72˚C for amplification, and the final
amplification step of 7 minutes at 72˚C.
The PCR product was analysed using 2% agarose gel electrophoresis, stained with ethidium
bromide, and visualized under ultraviolet illumination.
Sample size
Data used in the present analysis are from a hospital-based surveillance program (ViNaDia),
whose primary aim is to monitor diarrhea and RVA cases before and after Rotarix1 vaccine
introduction [17]. Since ViNaDia is an ongoing surveillance system, the sample size calcula-
tion was not estimated for the present analysis. However, we calculated the statistical power
associated to the obtained sample sizes to compare two proportions. For children aged up to
59 months, statistical power was 92.1%. For the secondary analysis in children younger than
24 months, the sample power was 88.0% (higher than 80% minimum required).
Data management and statistical analysis
Data collected was double entered in two similar databases by two independent typists in Epi
Info™3.5.1. (Centers for Disease Control and Prevention, Atlanta, 2008), followed by data com-
parison. IBM SPSS (International Business Machines Corporation Statistical Package for the
Social Science, Armok, NY: IBM Corp, 2011, version 26.0) software was used to conduct the
data analysis.
Overall RVA frequencies with the corresponding Wilson’s 95% Confidence Interval (CI)
were estimated, for each RVA vaccine period and year [30]. Also, RVA proportions by age (in
months) groups for each year were calculated.
Descriptive statistics and chi-square test or Fisher’s Exact test were used to identify socio-
demographic and epidemiological variables associated with RVA infection in each vaccine
period in children age up to 59 months and in children younger than 24 months (S1 Table).
Due to the absence of RVA cases among children aged between 24–59 months in the post-vac-
cine period, a more detailed analysis was done to children under 24 months. Multiple logistic
regression models were explored to obtain adjusted odds ratio (aOR), with 95% confidence
intervals, for each vaccine period. The bivariate analysis of the socio-demographic and epide-
miological characteristics for children under 24 months of age is shown in S1 Table. Variables
with initial p< 0.05 were included in the multiple logistic regression model for children under
24 months of age. Goodness-of-fit of the multiple logistic regression models was obtained
using Hosmer and Lemeshow test.
For children aged up to 59 months, clinical factors associated with RVA infection in each
vaccine period and in general were assessed by cross-tabulation followed by the chi-square test
or Fisher’s Exact test if assumptions were not met. Cross-tabulation was performed between
vaccination status and RVA infection; vaccination status and genotype distribution; age and
genotype distribution. Parameter estimation was done using 95% confidence interval, and
hypothesis test were based on a 5% level.
Ethical statement
The study protocol was approved by the National Bioethics Committee for Health in Mozam-
bique (IRB00002657, reference 348/CNBS/13). Parents or legal guardians of the children
signed or provided their fingerprint to the informed consent form, which described the study
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objectives and clarified that participation in the study was voluntary. Data confidentiality was
ensured by storing the physical data collection and consent forms in a lockable cabinet with
limited access.
Results
Overall and yearly RVA frequencies by vaccination period
In total, 700 children were recruited by ViNaDia in Nampula hospital (221 from the pre-vac-
cine period and 479 from the post-vaccine period), of which 614 (87.7%) provided a stool sam-
ple for laboratory procedures, (192 from the pre-vaccine period and 422 from the post-vaccine
period).
Overall, 25.9% (159/614) of the children were positive for RVA- 95% CI: 22.6–29.5. RVA
infection was more frequent in the pre-vaccine (2015) period [34.9% (95% CI: 28.5–41.9);
67/192] than in the post-vaccine (2016–2019) period [21.8% (95% CI: 18.1–26.0); 92/422]
(p = 0.001). RVA frequency by year after vaccine introduction was 14.6% (29/198) in 2016,
37.5% (45/120) in 2017, 14.8% (8/54) in 2018 and 20.0% (10/50) in 2019 (Fig 1).
RVA frequency by age group and year
RVA infection was more frequent among children under 12 months of age than the older ones
in each analyzed year, 43.4% (36/83) in 2015, 24.0% (23/96) in 2016, 45.5% (30/66) in 2017,
19.2% (5/26) in 2018 and 27.6% (8/29) in 2019 (Fig 2). RVA infection in children between 24–
59 months was only observed in the pre-vaccine period, 14.3% (6/42). Each year, the median
age (in months) of positive children was below 12 months, in which the third quartile was
lower than 24 months, being 11 (8–15) for 2015, 9 (7–11) for 2016, 10 (8–12.5) for 2017, 8.5
(7.25–12) for 2018 and 9.5 (8–11.25) for 2019.
Fig 1. Frequency of RVA infection by year and their Wilson’s confidence intervals.
https://doi.org/10.1371/journal.pone.0255720.g001
Fig 2. Frequency of RVA per year and children age groups in Hospital Central de Nampula.
https://doi.org/10.1371/journal.pone.0255720.g002
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Potential risk factors for RVA infection in pre- and post-vaccine period in
Hospital Central de Nampula
In the pre-vaccine period, RVA infection was more frequent in children younger than 12
months (p< 0.010) (Table 1). Exclusive breastfeeding (44.4%; 32/72; p< 0.028); drinking
water from a piped source (54.7%; 35/64; p< 0.001) and Borehole/well (18.8%; 13/69;
p< 0.001) were also associated with RVA infection in the pre-vaccine period. Underweight
was negatively associated with RVA infection, as the infection was more frequent in well-nour-
ished children (42.2%; 43/102; p< 0.003) (Table 1).
Similarly, to the pre-vaccine period, in the post-vaccine period, the child’s age and weight-
for-age were also associated to RVA infection, p< 0.001 and p = 0.044 respectively. Several
factors that were not associated with RVA infection in the pre-vaccine period were associated
with RVA infection in the post-vaccine period. These included animal contact (27.1%; 75/277;
p< 0.001) and weaning within the first six months of life (27.3%; 3/11; p = 0.004) (Table 1).
Type of animal which children had contact in pre- and post-vaccine periods
The animal species that children had contact in pre- and post-vaccine periods show that none
of the animals were associated with RVA infection in pre-vaccine period (Table 2). However,
it was observed an association between chicken contact (37.2%; 29/78; p<0.001); duck (37.0%;
17/46; p = 0.008), or multiple animals (30.6%; 34/111; p = 0.009) contact with RVA infection
in the post-vaccine period (Table 2).
In the multivariable analysis for the pre-vaccine period, children from household’s that
drunk piped water had 2.49 times greater odds of being infected by RVA compared to the chil-
dren who did not drink piped water (aOR = 2.49, 95% CI: 2.49 1.04–5.95; p< 0.040) (Table 3).
In the post-vaccine period, children between 0–11 months of age were 1.83 times more
likely of being infected by RVA than the children between 12–23 months (aOR = 1.83; 95% CI:
1.07–3.13; p = 0.028). After Rotarix1 introduction, year 2017, was the one with the highest
chances of infection by RVA compared to 2019 (aOR = 2.40; 95% CI: 1.05–5.50; p = 0.038).
Children with animal contact were 1.92 times more likely to be infected by RVA compared to
children without animal contact (aOR = 1.92; 95% CI: 1.01–3.66; p = 0.048) (Table 3).
Clinical factors related to RVA infection in children from Hospital Central
de Nampula
Overall, the factors related to RVA infection were a greater number of diarrhea episodes in
the last 24h before admission (p = 0.041); and the occurrence of vomiting (30.6%; 126/418;
p< 0.001) (Table 4). In the pre-vaccine period occurrence of fever was the only clinical factor
related to RVA infection (48.4%; 15/31; p = 0.038) (Table 4).
In the post-vaccine period, clinical factors related to infection by RVA, were the number of
diarrhea episodes in the last 24h, infection was more common in children with four or more
episodes (p< 0.01); and occurrence of vomit (27.1%, 72/266; p = 0.001) (Table 4).
RVA infection by vaccination status of the children in Hospital Central de
Nampula
A stratified analysis between RVA infection and vaccination status was performed for the
post-vaccine period, and RVA infection was more common in partially vaccinated children
(40.7%, 11/27) followed by the fully vaccinated (29.3%, 56/191) and unvaccinated (15.3%, 21/
137) (p = 0.002).
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Age categorized (in months) 0.005 <0.001
0–11 36/83 43.4 66/217 30.4
12–23 25/67 37.3 26/132 19.7
24–59 6/42 14.3 0/73 0.0
Sex 0.056 0.922
Male 30/104 28.8 56/255 22.0
Female 37/88 42.0 36/167 21.6
Exclusive breastfeed 0.028 0.947
Yes 32/72 44.4 14/63 22.2
No 34/118 28.8 78/357 21.8
Animal contact 0.843 <0.001
No 56/161 34.8 17/145 11.7
Yes 11/30 36.7 75/277 27.1
Source of drinking water
Public tap 0.628 0.483
No 48/134 35.8 31/155 20.0
Yes 17/53 32.1 61/266 22.9
Piped water <0.001 0.967
No 30/123 24.4 74/338 21.9
Yes 35/64 54.7 18/83 21.7
Borehole/well <0.001 0.327
No 52/118 44.1 80/352 22.7
Yes 13/69 18.8 12/69 17.4
River/lake/lagoon 1.000 a 1.000 a
No 65/186 34.9 92/419 22.0
Yes 0/1 0.0 0/2 0.0
Purchased/bottled water NA 0.219 a
No 65/187 34.8 91/420 21.7
Yes 0/0 0.0 1/1 100.0
Age weaning in months (categorized) 0.579 a 0.004 a
0–6 1/4 25.0 3/11 27.3
7–12 2/20 10.0 3/18 16.7
13–24 4/30 13.3 1/68 1.5
25–59 1/5 20.0 0/4 0.0
HIV 0.446 1.000 a
Negative 54/163 33.1 30/183 16.4
Positive 4/8 50.0 2/13 15.4
Underweight (weight-for-age) 0.003 0.044
No 43/102 42.2 64/262 24.4
Yes 12/62 19.4 23/145 15.9
a Fisher’s Exact Test.
NA: Not Applicable.
https://doi.org/10.1371/journal.pone.0255720.t001
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The most common strains identified were G9P[6] (33.3%; 4/21) in the unvaccinated chil-
dren, G9P[4] (45.5%; 5/11) in the partially vaccinated, and G1P[8] (30.4%; 17/56) in the fully
vaccinated. Also, most diversity was found in the fully vaccinated children, including the
uncommon combinations such as G3P[4] with 10.7% (6/56) and G9P[4] with 17.9% (10/56).
Non-typeable samples were also found in fully vaccinated children. The mixed infection
(G1G3P[8]) were most common in the partially vaccinated group, with 18.2% (2/11) (Table 5).
RVA genotypes distribution by age group in pre- and post-vaccine period
in Hospital Central de Nampula
Sixty out of sixty-seven (89.6%) RVA positive samples from the pre-vaccine period had a suffi-
cient amount for RT-PCR. G1P[8] genotype combination was the most common among chil-
dren younger than 24 months of age (45/55) (Fig 3., S2 Table).
All RVA positive samples collected in the post-vaccine period were submitted to molecular
characterization and were from children below 24 months of age. The G1P[8] was the most
common with 28.3% (26/92). However, in children younger than 12 months of age, a higher
frequency of emergent strains that were not detected in the pre-vaccine period were observed,
including mixed infections. In the older group (12–23 months) G1P[8] 100% (22/22) was the








No 66/190 34.7 90/418 21.5
Yes 1/1 100.0 2/4 50.0
Goat NA 0.595a
No 67/191 35.1 86/400 21.5
Yes 0/0 0.0 6/22 27.3
Mouse 1.000a 0.226
No 66/189 34.9 67/327 20.5
Yes 1/2 50.0 25/95 26.3
Dog 0.659a 0.956
No 66/186 35.5 78/357 21.8
Yes 1/5 20.0 14/65 21.5
Duck NA 0.008
No 67/191 35.1 75/376 19.9
Yes 0/0 0.0 17/46 37.0
Chicken 1.000a <0.001
No 66/189 34.9 63/344 18.3
Yes 1/2 50.0 29/78 37.2
Cat 0.865 0.826
No 60/172 34.9 65/302 21.5
Yes 7/19 36.8 27/120 22.5
Multiple animals 1.000a 0.009
No 67/190 35.3 58/311 18.6
Yes 0/1 0.0 34/111 30.6
NA—Not applicable.
a Fisher’s Exact Test.
https://doi.org/10.1371/journal.pone.0255720.t002
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Table 3. The adjusted odds ratio for infection by RVA in pre- and post-vaccine periods, in children below 24 months.
Characteristics Pre-vaccine Post-vaccine
p aOR (95% CI) p aOR (95% CI)
Age (in months)




Female 0.097 1.83 (0.90–3.75) 0.873 1.04 (0.62–1.75)
Year of admission NA 0.004
2015 NA NA
2016 NA 0.814 0.90 (0.38–2.15)
2017 NA 0.038 2.40 (1.05–5.50)
2018 NA 0.687 0.80 (0.28–2.34)
2019 NA Ref
Animal contact
No NA NA Ref
Yes NA NA 0.048 1.92 (1.01–3.66)
Source of drinking water
Piped water
No Ref NA NA
Yes 0.040 2.49 (1.04–5.95) NA
Borehole/well
No Ref NA NA






Table 4. Clinical factors related to infection by RVA in general and by vaccine period.
Characteristics Overall p Pre-vaccine p Post-vaccine p
% (n/N) % (n/N) % (n/N)
Admission type 0.924 0.315 a 0.324
Inpatient 26.0 (143/551) 35.4 (67/189) 21.0 (76/362)
Outpatient 25.4 (16/63) 0.0 (0/3) 26.7 (16/60)
Diarrhea episodes in the last 24h 0.041 0.625 0.008
1–3 18.1 (23/127) 31.4 (16/51) 9.2 (7/76)
4–5 29.8 (89/299) 39.7 (31/78) 26.2 (58/221)
�6 25.0 (36/144) 37.5 (9/24) 22.5 (27/120)
Vomiting <0.001 0.270 0.001
No 16.1 (31/193) 27.5 (11/40) 13.1 (20/153)
Yes 30.6 (128/418) 36.8 (56/152) 27.1 (72/266)
Fever 0.436 0.038 0.908
No 25.9 (90/347) 28.6 (32/112) 24.7 (58/235)
Yes 29.4 (42/143) 48.4 (15/31) 24.1 (27/112)
a Fisher’s Exact Test.
https://doi.org/10.1371/journal.pone.0255720.t004
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only genotype reported in the pre-vaccine period (Fig 3). In contrast, in the post-vaccine
period, other strains, such as G9P[6] (19.2%, 5/26) and G9P[4] (15.4%, 4/26), were also
reported (Fig 4, S3 Table).
Monthly distribution of RVA infection in pre- and post-vaccine period
Since the introduction of the vaccine in the country, the number of diarrhea and RVA cases
have declined, mostly since late 2017 at Hospital Central de Nampula. RVA cases occurred in
both seasons, cold/dry and wet/rainy. The frequency of RVA during the cold/dry season (April
to September) was 35.8% (108/302) and in the wet/rainy season (October to March) was 16.3%
(51/312) (p< 0.001) (Fig 5).
Discussion
We investigated the epidemiology of RVA, and the distribution of genotypes by vaccination
status and age among children with diarrhea attending Hospital Central de Nampula, in
Nampula province northern region of the country. Our analysis showed that RVA infection
Table 5. RVA genotypes combination identified by vaccination status in the post-vaccination period.
Genotypes Vaccination status
Unvaccinated % Vaccinated (first dose) % Vaccinated (full doses) %
G1P[8] 4 19.0 1 9.1 17 30.4
G2P[6] 1 4.8 0 0.0 3 5.4
G3P[4] 0 0.0 0 0.0 6 10.7
G3P[8] 0 0.0 0 0.0 2 3.6
G9P[4] 5 23.8 5 45.5 10 17.9
G9P[6] 7 33.3 1 9.1 8 14.3
G9P[8] 0 0.0 1 9.1 0 0.0
G12P[8] 0 0.0 1 9.1 0 0.0
G1G3P[8] 1 4.8 2 18.2 1 1.8
G9P[X] a 0 0.0 0 0.0 1 1.8
GXbP[4] 0 0.0 0 0.0 5 8.9
GXbP[6] 2 9.5 0 0.0 0 0.0
GXbP[8] 0 0.0 0 0.0 1 1.8
GXbP[X] a 1 4.8 0 0.0 2 3.6
Total 21 100.0 11 100.0 56 100.0
a Refers to strains that were non-typeable for P.
b Refers to strains that were non-typeable for G.
https://doi.org/10.1371/journal.pone.0255720.t005
Fig 3. RVA genotypes distribution by age groups in the pre-vaccine period; N = 60.
https://doi.org/10.1371/journal.pone.0255720.g003
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declined following vaccine introduction by 13.1%. In comparison, two other studies in Maputo
city, a southern region of the country, found a drop in RVA infection of 31.2% and 14.2%
respectively [23, 31]. The differences observed can be explained by the lower vaccine coverage
in Nampula province (46%) compared to Maputo city (61%) (data not published from the
Expanded Program on Immunization) in 2016, and the lower health indicators in Nampula
province [32].
Despite the reduction in RVA morbidity during the post-vaccine period, an increase in
RVA infection frequency was seen in 2017. This event may be explained by the lower RVA vac-
cine coverage [33], and the impact of increasing the surveillance after introducing of RVA vac-
cine in the country.
After the vaccine introduction, there was a reduction of RVA infection in different age
groups, with a significant decrease among children from 24–59 months of age. However, the
frequency of RVA infection remains high in children under 12 months of age. This finding dif-
fers from an analysis from Hospital Geral de Mavalane and Hospital Central de Maputo, which
reported a substantial reduction of RVA infections among children under 12 months of age,
with a shift to older age-groups [14, 23].
Differences in the age infection shifting may be due to lower vaccination coverage in Nam-
pula [32], reinforced by our data in which 38.6% of the children were not vaccinated even
being eligible for vaccination in post-vaccine period.
Fig 4. Genotypes distribution by age groups in the post-vaccine period; N = 92.
https://doi.org/10.1371/journal.pone.0255720.g004
Fig 5. Monthly distribution of RVA infection between March 2015 and December 2019.
https://doi.org/10.1371/journal.pone.0255720.g005
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RVA is a zoonotic agent with a risk of interspecies transmission [34, 35]. In Chókwè, a rural
area of Mozambique, phylogenetic data of G4P[6] strain detected in children, clustered with
porcine and human porcine-like strains [14]. Animal contact with duck, chicken or multiple
animals points to a potential association of RVA interspecies transmission. The occurrence
of RVA in chickens was reported in Nigeria [36] and Kenya [37]. Furthermore, a study con-
ducted in Germany identified an avian VP4 gene, strain P [37] closely related to mammalian
RVA [38]. These data highlight the need of expanding the RVA surveillance to domestic ani-
mals in Mozambique.
Mozambique has problems related to the availability of water and as a strategy to
mitigate the scarcest; intermittently distribution of water between few hours during the day
was adopted, which forces households to storage the water in recipients for long use. Our
surveillance has limited information on the conditions that the piped water were stored, or
in what extent would be safe for consumption after storage. Most of the Mozambican pipe-
lines are old and damaged in some sections aligned with the fact that are not properly main-
tained [39, 40], which can contribute for contamination of the piped water mainly in flood
situation as the supply network are emerged [39, 41, 42]. A recent study conducted in the
capital of the country (Maputo), which analyzed different sources of water (home bottled,
piped and supply well water) observed higher microbiological contamination than recom-
mended for human consumption in piped water [42]. Although the study was carried out
in Maputo, the company that supplies water at the national level is the same. If so, this find-
ing helps to explain the high frequency of RVA in children who consume piped water in
Nampula.
The Demographic and Health Survey showed that only 43% of the children under six
months are solely breastfed in Mozambique [19]. Surprisingly in this analysis, RVA infection
was more common in children exclusively breastfeed. Similar results were reported in Kenya
in children under 24 months, where a high proportion of positive children were exclusively
breastfed than those with other types of food, with 16% and 10.3% respectively in the post-vac-
cine period [43]. One of the hypotheses behind this finding is related to the maternal antibod-
ies which may interfere with the RVA vaccine efficacy in lower and middle-income countries,
however, the causal link is not well described [44].
The fact that the proportion of RVA infected children with fever, vomiting, multiple diar-
rhea episodes, or visit requiring hospitalizations decreased in the post-vaccine period, may
highlight the role of vaccination in reducing the severity of RVA infection [45, 46].
More than one-third of the children who received only the first dose of vaccine had a high
frequency of RVA infection, which raises the question of whether they are shedding the vac-
cine strain. Vaccine shedding was accessed and the minimum days between the symptoms
onset and the vaccination day for dose one were 32 days and for dose two were 26 days (data
not shown), which excludes the possibility of shedding [47]. This result indicates a need for
further research in Nampula to understand which factors are behind the high frequency of
infection in vaccinated children.
Different genotype combinations in the three groups of children; the unvaccinated, partially
vaccinated, and fully vaccinated were observed. The combination G1P[8] was the most com-
mon in fully vaccinated children. The fact that vaccinated children hospitalized due to RVA
infection, with the same genotype from the vaccine, may be related to the high prevalence of
chronic malnutrition in this province (55%), the highest in the country [19]. It is known that
malnutrition can impair the immune system and weaken the vaccine’s immune response [48,
49]. However, this hypothesis cannot be tested in this analysis due to study design, and we can-
not rule out other factors as concomitant enteric infections, histo-blood group antigen, micro-
biota composition and mothers antibodies [50, 51].
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An increased number of strains reported as uncommon such as G3P[4], G9P[4], G9P[6],
G2P[6], G12P[8] and non-typeable were observed mainly in fully vaccinated children,
highlighting the importance of the continuous surveillance.
The G1P[8] strain was the most common genotype combination in all age groups before
the introduction of the vaccine. A high genotype diversity after vaccine introduction was
observed in children under 12 months of age. Our findings are not concordant with a study
conducted in the southern region of the country in which the diversity of RVA genotypes
strains were observed in all age groups during both periods [31]. Also, in Turkey, genotype
diversity was common in children from 13 to 24 months of age [52].
Regardless of the vaccine period, RVA was more common in the dry/cold season (April—
September) than in the wet/rainy season (October—March), as expected [23, 31].
The study findings should be interpreted carefully as the following limitations were identi-
fied i) variables with non-response in the forms, even with continuous training of the staff, ii)
unbalanced sample size between pre and post-periods and small sample size to some sub-
groups, iii) time period in the pre-vaccine was lower than the ideal minimal two years’ period
(March—December 2015). However, our sample size meets the minimum sample power
(80%) of the main hypothesis tests. This study was carried out at a quaternary-level hospital,
which probably included only children with severe disease, where the epidemiological distri-
bution of the disease may be different from hospitals at other levels (tertiary, secondary, rural,
post). Despite the limitations, we were able to describe the epidemiology of RVA infection at
HCN and the risk factors related to infection in each period (pre- and post-vaccine periods).
Some questions need to be addressed, such as: (i) the reason why vaccinated children are
infected with RVA to the point of requiring hospitalization; (ii) the role of animals in the
occurrence of new/uncommon RVA genotypes to optimize the vaccination.
In conclusion, RVA infection was high in Hospital Central de Nampula even after vaccine
introduction, mostly in children under 12 months. During the pre-vaccine period, piped water
was associated with RVA infection, however, additional studies are needed to investigate this
association. In contrast, after vaccine introduction, risk factors for RVA infection were age (0–
11 months) and contact with animal (chicken, duck and multiple animals). The infection was
more common in vaccinated children, G9P[4] and G1G3P[8] were the most common geno-
types in partially vaccinated, while in fully vaccinated G1P[8], G9P[6], and G9P[4] were the
most common. Our results show a need for further research to understand the factors behind
RVA infection in vaccinated children such as the vaccine immune response and factors that
contribute to strains diversity through the whole genome sequence and phylogenetic analysis
in Nampula.
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8. Bányai K, László B, Duque J, Steele AD, Nelson EAS, Gentsch JR, et al. Systematic review of regional
and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for
understanding the impact of rotavirus vaccination programs. Vaccine. 2012; 30 Suppl 1:A122–130.
https://doi.org/10.1016/j.vaccine.2011.09.111 PMID: 22520121
9. Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, et al. Rotavirus disease and vac-
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23. de Deus N, Chilaúle JJ, Cassocera M, Bambo M, Langa JS, Sitoe E, et al. Early impact of rotavirus vac-
cination in children less than five years of age in Mozambique. Vaccine. 2018; 36:7205–9. https://doi.
org/10.1016/j.vaccine.2017.10.060 PMID: 29128381
PLOS ONE Rotavirus A infection in pre-and post-vaccine periods in Nampula Province, Mozambique
PLOS ONE | https://doi.org/10.1371/journal.pone.0255720 August 6, 2021 15 / 17
24. Bauhofer AFL, Cossa-Moiane I, Marques S, Guimarães EL, Munlela B, Anapakala E, et al. Intestinal
protozoan infections among children 0–168 months with diarrhea in Mozambique: June 2014—January
2018. PLoS Negl Trop Dis. Public Library of Science; 2020; 14:e0008195. https://doi.org/10.1371/
journal.pntd.0008195 PMID: 32320399
25. Gouvea V, Glass RI, Woods P, Taniguchi K, Clark HF, Forrester B, et al. Polymerase chain reaction
amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol. 1990; 28:276–
82. https://doi.org/10.1128/jcm.28.2.276-282.1990 PMID: 2155916
26. Gentsch JR, Glass RI, Woods P, Gouvea V, Gorziglia M, Flores J, et al. Identification of group A rotavi-
rus gene 4 types by polymerase chain reaction. J Clin Microbiol. 1992; 30:1365–73. https://doi.org/10.
1128/jcm.30.6.1365-1373.1992 PMID: 1320625
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